SEC Form 4
Sabra Healthcare REIT, Inc. (SBRA) insider trading
In the 12 months to Oct 24, 2026, 2 SBRA insiders reported open-market sales of $4.5M across 2 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $4.5M
- 2 filings · 2 insiders
- Open-market purchases
- $0
- 0 filings
- Pre-arranged sales (10b5-1)
- 1 of 2
- $4.2M of $4.5M sold (93%)
Who traded SBRA, and when
- Sale
- Sale, pre-arranged (10b5-1)
SBRA daily close from Oct 24, 2025 to Oct 23, 2026, between $17.23 and $22.39, last $19.56. 2 sale and 0 purchase filings by 2 insiders, marked at their filing dates. Richard K. Matros, Chair, CEO and President: sold $4.2M across 1 filing, first filed Sep 9, 2026, last Sep 9, 2026. Jessica Flores, Executive VP & CAO: sold $302.5K across 1 filing, first filed Mar 26, 2026, last Mar 26, 2026.
Largest mark · tap a row for others
Richard K. Matros · Chair, CEO and President
Sale $4,166,000
200,000 shares at $20.83 avg
Filed Sep 9, 2026 · traded Sep 8
Pre-arranged (10b5-1) · close on filing date $20.79
Richard K. Matros · Chair, CEO and President
Chair, CEO and President
$4.2M soldJessica Flores · Executive VP & CAO
Executive VP & CAO
$302.5K soldHas Sabra Healthcare REIT, Inc.'s CEO sold stock?
Yes. Richard K. Matros (CEO) sold 200,000 shares ($4.2M) in Sep 2026, all under a pre-arranged 10b5-1 plan.
Open-market trades
2 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Richard K. Matros | Chair, CEO and President | $4.2M | — | 1 | 100% of sales | |
| Jessica Flores | Executive VP & CAO | $302.5K | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Richard K. Matros Chair, CEO and President | SalePre-arranged (10b5-1) | 200,000 | $20.83 | $4.2M | 1,657,686 | |
traded | Jessica Flores Executive VP & CAO | Sale | 15,231 | $19.86 | $302.5K | 71,709 |
GET /stocks/filings/vX/form-4?tickers=SBRA&filing_date.gte=2025-10-24&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"SBRA"
],
"issuer_cik": "0001492298",
"owner_cik": "0001184158",
"accession_number": "0001184158-26-000016",
"form_type": "4",
"filing_date": "2026-09-09",
"period_of_report": "2026-09-08",
"issuer_name": "Sabra Health Care REIT, Inc.",
"issuer_trading_symbol": "SBRA",
"owner_name": "MATROS RICHARD K",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chair, CEO and President",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-09-08",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 200000,
"transaction_price_per_share": 20.83,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 1657686,
"transaction_value": 4165999.9999999995,
"not_subject_to_section_16": false,
"direct_or_indirect": "I",
"nature_of_ownership": "By R&A Matros Revocable Trust",
"footnotes": [
{
"id": "F1",
"description": "The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2026."
},
{
"id": "F2",
"description": "The price report in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.66 to $20.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
}
]
},
{
"tickers": [
"SBRA"
],
"issuer_cik": "0001492298",
"owner_cik": "0002003768",
"accession_number": "0002003768-26-000012",
"form_type": "4",
"filing_date": "2026-03-26",
"period_of_report": "2026-03-25",
"issuer_name": "Sabra Health Care REIT, Inc.",
"issuer_trading_symbol": "SBRA",
"owner_name": "FLORES JESSICA",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Executive VP & CAO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-03-25",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 15231,
"transaction_price_per_share": 19.86,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 71709,
"transaction_value": 302487.66,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The price report in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.85 to $19.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
},
{
"id": "F2",
"description": "Includes 25,527 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 72 records
- Tax withholding9 records
- Grants and awards58 records
- Gifts5 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for SBRA every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.